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Abstract: The preferred surgical fixation of forearm shaft fractures in children is Elastic Stable
Intramedullary Nailing (ESIN). Due to known disadvantageous effects of metal implants, a new
surgical method using biodegradable polylactide-co-glycolide (PLGA) intramedullary nails has
been developed but its long-term outcomes are unclear. The aim of this study was to compare
the long-term outcomes of Biodegradable Intramedullary Nailing (BIN) to ESIN and assess the
biodegradation of the study implants via magnetic resonance imaging (MRI). The study population
of the prospective, randomized trial consisted of paediatric patients whose forearm shaft fractures
were treated with BIN (n = 19) or ESIN (n = 16). Forearm rotation at minimally four years’ follow-up
was the main outcome. There was no clinically significant difference in the recovery of the patients
treated with the BIN as compared to those treated with the ESIN. More than half of the implants
(57.7%, n = 15/26) were completely degraded, and the rest were degraded almost completely. The
PLGA intramedullary nails used in the treatment of forearm shaft fractures in this study resulted in
good function and anatomy. No unexpected disadvantages were found in the degradation of the
implants. However, two implant failures had occurred in three months postoperatively.
Keywords: biodegradable fracture fixation; forearm fracture; paediatric; long-term outcomes; mag-
netic resonance imaging (MRI)
1. Introduction
In traumatology, bioabsorbable implants have been used in different indications for
several decades with promising outcomes [1–9]. The traditional fixation methods have
some disadvantages that the techniques using biomaterials and their distinct features aim
to overcome. The degradation of biodegradable polymers occurs mainly via hydrolysis
and secondarily through non-specific enzymatic pathways. The degradation rate depends
on the geometry and size of the implant as well as molecular characteristics, such as the
ratio of different copolymers [3]. Contrary to conventional implant materials, such as
titanium alloy, biodegradable implants are not inert in the human body and foreign-body
reaction is evident [2,3]. This inflammatory tissue response is in most cases clinically not
important [2]. However, osteolysis with biodegradable devises is considered to be the most
common adverse event of these implants in orthopaedic practice [10,11].
Forearm fractures are common in the paediatric population, accounting for up to
36% of all fractures [12]. In most cases, these fractures can be treated via closed reduction
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and plaster cast immobilization with good outcomes. Diaphyseal forearm fractures have
less remodelling potential than metaphyseal fractures; thus, the limitations of acceptable
alignment are lower than for distal metaphyseal or physeal fractures [13]. With paediatric
diaphyseal forearm fractures, operative treatment should be reserved for patients whose
fracture alignment cannot be achieved through closed means [14]. Hence, irreducible
fractures or fractures that fail to maintain satisfactory reduction require osteosynthesis
to achieve healing without producing anatomical or functional abnormalities [15,16]. In
addition, severe open fractures and fractures with neurovascular compromising or com-
partment syndrome are indications for operative treatment. Schmittenbecher offers a
treatment algorithm for forearm shaft fractures in children in which unstable or irreducible
fractures and fractures with final axial deviation >10◦ should be treated operatively [15].
He encourages to manage every patient by a primary definitive method to avoid more
than one surgical intervention. Complete shaft fracture of both bones on the same level,
with oblique fracture lines and convergent displacement, is classified as unstable forearm
shaft fracture. The predicting factors of conservative treatment failure include casting
index ≥0.84 [17], translational dislocation ≥10 mm, older age and male gender [18]. It has
been reported that the operative treatment of these fractures has become more frequent in
developed countries [14,19].
Elastic stable intramedullary nailing (ESIN) is currently the recommended operative
treatment of forearm shaft fractures in children [14,20–28]. ESIN fulfils all the criteria of
minimally invasive bone surgery: shorter operating time, minimal soft-tissue dissection,
smaller incisions and thus smaller scars, less pain, and earlier mobilization [23]. ESIN is
an ideal procedure for a transverse diaphyseal forearm fractures in children and when
indications are correct and biomechanical principles are respected during application, rate
of complication is very low [27]. Alternatively, especially in pubertal teenagers, fixation
with plates and screws is an accepted option [14]. After bone healing, the intramedullary
nails are usually removed during a second operation. This has several disadvantages, such
as anaesthesia- and surgery-related risks, and concern, discomfort, and costs to the patients,
their families, and health care.
A novel procedure called biodegradable intramedullary nailing (BIN) has been de-
scribed [29]. The method is based on polylactide-co-glycolide intramedullary nails (Acti-
vaNail IM™) designed and manufactured for research purposes by Bioretec Ltd. (Tampere,
Finland). It was invented to obviate the disadvantages of ESIN in forearm shaft fractures.
The minimum of two years’ results of that pioneering RCT study with biodegradable
intramedullary nailing have been published previously by Korhonen et al. [30]. However,
none of the patients in that preliminary study showed complete degradation of their im-
plants via magnetic resonance imaging (MRI). Hence, the final outcomes of the technique
and the evolution of the implants used in these patients has remained unclear. Further
study was warranted to get a more precise idea of radiographic and functional outcomes
in a longer time frame.
In this study, we aimed to investigate the long-term functional and radiographic
outcomes of the operative treatment of children’s forearm fractures with biodegradable in-
tramedullary nails. The biodegradation process of biodegradable polylactide-co-glycolide
(PLGA) intramedullary nails is still unknown. Thus, we evaluated radiographic degrada-
tion at least four years after the operation.
2. Materials and Methods
2.1. Study Protocol and Patients
This is a prospective, randomized, controlled, clinical trial performed in two centers
in Finland, Oulu University Hospital, Oulu, Finland, and Central Hospital of Päijät-Häme,
Lahti, Finland, between November 2011 and January 2020. Patient enrolment occurred
between November 2011 and January 2015. All consecutive patients, aged between five and
15 years, who suffered from single or both bone forearm shaft fracture requiring surgical
fixation were aimed to be invited. After operating 1–2 preliminary cases per study institute
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with the new study procedure, all eligible participants were randomized into two study
groups for treatment either by BIN or ESIN. A research assistant, who was not involved in
the operative treatment, was responsible for the randomization using varied block sizes
to achieve 19 sealed envelopes per group. These envelopes were delivered to the study
institutions upon request. When parents or the guardians signed the informed consent,
a nurse at the ward not involved in the operative treatment of the patient opened one of
these envelopes for the operating surgeon, who as part performed the procedure according
to randomization [30].
Patients with open fractures, significant soft-tissue injury, pathological fractures or
previous fracture or infection in the forearm were excluded. In addition, patients with
metabolic bone diseases, systemic disease or medication affecting the bone quality, and
resistance to infection or fractures older than seven days were excluded [30].
The study design and power analysis have been described in detail previously, when
the short-term outcomes were concerned. It was calculated that 13 patients per group
would be needed. To obviate the problems with possible drop-outs, an excess of minimum
20% per group was decided [30].
ESIN implants used in this study were Synthes TEN™ (DePuy Synthes, West Chester,
PA, USA) implants. Their thickness was aimed to be 0.4 fold, compared to the minimum
thickness of the intramedullary canal. ActivaNail IM™ biodegradable intramedullary nails
were used in the BIN group, and the implants were produced by Bioretec Ltd, Tampere,
Finland. There were three thickness of the nails available: 2.0 mm, 2.7 mm, and 3.2 mm. The
PLGA nail is straight and without a curved tip. As great thickness as possible was selected,
according to the diameter of the intramedullary canal; thickness was evaluated both with
preoperative radiographs and by using the reamers intraoperatively. The hydrolytically
activated memory effect of the implant material increases the nail diameter and decreases
nail length by 1–2%, which may increase the stability of the fixation. The surgical technique
of BIN was originally described in a comprehensive technical report in 2013 [29]. According
to the study plan, all operated extremities were immobilized by using the above-the-elbow
cast, regardless of the implants. The titanium ESIN implants were removed by default in
every patient 4 to 6 months postoperatively.
Altogether, 35 patients were first recruited: 19 were treated with BIN and 16 with ESIN.
However, two cases treated with BIN suffered from new injuries resulting in re-fracture,
and another two cases lost reduction unexpectedly [30] (Figure 1). One patient in the
ESIN group did not complete the long-term follow-up due to them contracting a severe
disease. Thus, the number of the patients at the final follow-up was 15 for both groups.
A biodegradable nail was introduced to both forearm bones in 11 patients, to the ulna in
three patients, and to the radius in one patient; the total number of bones with BIN fixation
was 26. Thirteen out of 15 patients with ESIN were treated with both bone fixation and two
had a nail in the radius only.
J. Clin. Med. 2021, 10, 995 4 of 12
Figure 1. Flow chart of the randomized controlled trial in children with forearm shaft fractures treated either via bioab-
sorbable nailing (BIN) or elastic stable intramedullary nailing (ESIN). * The enrolment occurred between November 2011
and January 2015. ** Two patients suffered from implant failures. *** Two patients had high-energy injuries resulting in new
forearm fractures. **** One patient was not attending because of a serious illness.
The clinical and radiographic long-term outcomes were investigated at an outpatient
clinic visit at least four years after the operation between March 2019 and January 2020.
The mean follow-up was 6.7 ± 1.2 years for BIN and 6.9 ± 1.0 for ESIN (p = 0.668). The
mean age of the patients at follow-up was 17.2 ± 1.9 years in the BIN group and 17.1 ± 3.2
years in the ESIN group (p = 0.932). The male/female ratio was 5/10 for the BIN group
and 7/8 for the ESIN group (p = 0.0082). The patient characteristics and injury types are
presented in Table 1.
Table 1. Patient and Injury Characteristics.
BIN ESIN
Age (mean, y) * 10.2 ± 1.7 9.9 ± 3.2




Weight * 36.7 ± 11.4 35.0 ± 12.4
Fracture *
Both bone 18 15
Radius only 1 1
Ulna only 0 0
Mechanism of injury *
Fall 9 7
Trampoline jumping 6 6
Sports 4 3
*, at enrolment, n = 35; **, at four years visit, n = 30.
2.2. Clinical Investigation
The range of rotational movement in the forearm (degrees), wrist, and elbow move-
ments, carrying angles and grip/pinch strength (Nm) were determined. Clinical investiga-
tion included Flynn’s criteria for anatomical and functional outcomes, the MAYO elbow
performance score (0–100 points, with 100 points denoting the best possible performance),
and QuickDASH (Disabilities of Arm, Shoulder and Hand Score with 0% denoting no
disability, and 100% denoted most severe disability). Pain was recorded on a linear metric
visual analogue scale (VAS, 0–100) in mm ± standard deviation (SD).
2.3. Imaging
Anterior-posterior and lateral radiographs of both forearms were taken. The radio-
graphs were taken by means of digital radiography system on the bucky table with imaging
distance of 115 cm. The images were obtained according to the imaging instructions of
our institutes. The measurements were performed by paediatric radiologist with 20 years’
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experience in paediatric imaging (MP). The intra-rater reliability was assessed [30], and it
was found to be excellent, 0.941.
Tubularisation of the medulla, callus reabsorption, and visibility of the tri-calcium-
phosphate (β-TCP) tip of the biodegradable nail were observed from the plain films.
Diaphyseal angular deformity in both projections was measured. The length discrepancies
between the fractured and uninjured forearm bones of each patient were assessed. The
lengths of the radius and ulna were measured from the proximal end to the tip of the
processus styloideus in both bones.
MRI of the fractured forearm in the BIN group was performed using Siemens Magne-
tom Espree 1.5 Tesla or Siemens Magnetom Avanto 1.5 Tesla (Siemens, Erlangen, Germany)
equipment. The sequences were T1, STIR, and 3D T2 fat-saturated gradient echo in the
sagittal plane and T1 and T2 in the axial plane. The resorption of the nail shaft, as well
as the visibility of the nail canal, nail entrance, and β-TCP tip, was assessed. Intraosseal
oedema, the presence of continuous fatty medullary bone, and the possible formation of
intraosseal cysts were also detected. The interosseal membrane (IOM) between the radius
and ulna was examined in axial sequences. Soft tissue oedema and operation-related
artefacts were reported. The images were analysed by a paediatric radiologist with 20
years’ experience in paediatric imaging (MP).
2.4. Outcome Variables
The range of rotational movement in the forearm (degrees) was the main clinical
outcome in this study. Secondary outcomes included wrist and elbow movements and
grip/pinch strength, carrying angles, Flynn’s criteria, the MAYO elbow performance score
and QuickDASH. Pain, being also a secondary outcome, was recorded by using a visual
analogue scale (VAS). Secondary outcomes included imaging findings at the four-years
mark: bone remodelling, degradation of the biodegradable nails, and their tri-calcium-
phosphate (β-TCP) tips and other implant-related imaging findings.
2.5. Statistical Methods
For functional outcome, we did both per protocol (PP) and intention-to-treat (ITT)
analysis. In ITT analysis, the last available functional results were used from the drop outs.
Otherwise, the results included per protocol groups.
Differences in the functional outcomes between treatments were tested by Student’s
t-test. Standardized Normal Deviate (SND) test was used to compare differences in pro-
portions. 5% was considered to be the level of statistical significance (p < 0.05). All tests
were two-sided, and 95% confidence intervals (CI) were used. Statistical analyses were
performed by using IBM SPSS Statistics for Windows, Version 26 (IBM Corp., Armonk, NY,
USA) and StatsDirect, Version 3 (StatsDirect Ltd., Cambridge, UK) statistical software.
2.6. Ethical Aspects
The study plan was originally approved by the Medical Ethics Committee and the Hos-
pital Ethics Committee of Pirkanmaa Hospital District, Tampere, Finland (§R09231/2011)
and recorded in the annals of the Northern Finland Hospital District, Oulu, Finland. The
Medical Ethics Committee of Northern Finland Hospital District, Oulu, Finland approved
the extension of the study (30 January 2019, 112/2018). Permission for the study was also
approved by Päijät-Häme Central Hospital for the patients treated and re-examined at that
hospital (6 November 2019, D/2219/13.00.00.00/2019). The Finnish National Supervisory
Authority for Welfare and Health (Valvira, Helsinki, Finland) approved the implant in
question for the study purpose in this research-intended study. This study was re-registered
at ClinicalTrials.gov (NCT04385745), while the primary registration did not cover the exten-
sion of the study period. Written informed consent was obtained from eligible paediatric
patients and/or their guardians or the adult patients themselves.
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3. Results
3.1. Functional Results and Residual Symptoms
In PP analysis, the pronation of the forearm, flexion of the elbow, and volar flexion of
the wrist were slightly better in the BIN patients than the ESIN patients, with the pronation
being 79◦ (range 70◦–90◦) in the BIN group versus 73◦ (range 62◦–88◦) in the ESIN group
(p = 0.030). Flexion of the elbow was 154◦ (range 140◦–163◦) for the BIN group and 145◦
(range 135◦–153◦) in the ESIN group (p = 0.001). The volar flexion of the wrist measured 89◦
(range 80◦–100◦) in the BIN group and 83◦ (range 67◦–95◦) in the ESIN group (p = 0.023).
There were no significant differences between the groups in terms of the supination of the
forearm, extension of the elbow, or dorsiflexion of the wrist. When the functions of the
operated forearms were compared to the uninjured forearms of each patient, no significant
differences were revealed. The strength of the grip and pinch showed similar results in
both BIN and ESIN groups (Table 2).
Table 2. Functional results of the upper extremity at mean 6.8 years after forearm fracture operation





Mean SD * Mean SD 95% CI ** of theDifference p-Value ***
Supination (◦) 86.4 12.7 79.5 17.4 −4.5–18.3 0.228
Pronation (◦) 78.5 5.9 72.7 8.0 0.6–11.1 0.030
Flexion (elbow, ◦) 153.8 7.4 144.8 5.2 4.2–13.8 0.001
Extension (elbow, ◦) −8.1 5.9 −8.3 6.2 −4.2–4.8 0.905
Dorsiflexion (wrist, ◦) 86.9 14.6 80.2 9.8 −2.6–16.0 0.153
Volar flexion (wrist, ◦) 88.9 6.0 82.7 7.9 0.9–11.5 0.023
Grip (Nm) 29.6 10.9 31.7 14.4 −11.6–7.5 0.666
Pinch (Nm, n = 14) 6.6 2.7 5.9 2.4 −1.3–2.7 0.469
* SD = standard deviation; ** CI = confidence interval; *** p-value measured by using independent t-tests.
Analysis of the functional quantities in the ITT material showed statistically significant
differences in the prosupination of the forearm and the dorsal and volar flexion of the wrist.
With BIN patients, the prosupination of the forearm was 165◦ (SD 16◦) and with ESIN 148◦
(SD 24◦) (95% CI 1.4 to 31.8, p = 0.033). The combined dorsal and volar flexion of the wrist
measured 176◦ (SD 17◦) with BIN and 163◦ (SD 13◦) with ESIN (95% CI 1.5 to 23.4, p = 0.028).
The mean carrying angle of the upper extremity was 14.9◦ (SD 4.7◦) in the BIN group
and 14.4◦ (SD 5.1◦) in the ESIN group (95% CI −3.3 to 4.1, p = 0.81). There was no difference
in the carrying angles when the fractured arms (14.7◦, SD 4.8◦) were compared to the
uninjured arms (13.6◦, SD 7.2◦) (95% CI −2.2 to 4.3, p = 0.523).
Fourteen out of 15 patients (93%) in the BIN group and 13 out of 15 (87%) in the ESIN
group achieved the maximum 100 points in their Mayo elbow performance scores (95% CI
of difference −19% to 33%, p = 0.999). The mean score for the BIN patients was 99.0 (SD
1.87) and for the ESIN group 98.0 (SD 3.47). The reason for the decrease in the score was
mild pain in all three patients who did not achieve full points. The results of QuickDASH
were similar in both groups, with the mean score for the BIN group being 0.75% (SD 2.04%)
and for the ESIN group 0.61% (SD 1.81%), denoting close to full ability. With the ESIN,
there were four (27%) patients who reported pain in the VAS and none in the BIN group
(95% CI on difference −8% to 47%, p = 0.186), although one patient reported mild pain
in their Mayo elbow performance score. The mean value of pain with ESIN was 1.8 mm
(range 1–20, SD 4.5 mm).
3.2. Degradation of the Biodegradable Implants
The PLGA implants of the BIN group were completely absorbed in 15 out of 26 bones
(58%, 95% CI 37% to 77%) and almost completely absorbed in 11 bones, according to the MR
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images. The nail residuals appeared as faint, linear, low-signal short markings (Figure 2).
The nail canal disappeared completely in 20 (77%, 95% CI 56% to 91%) forearm bones
and almost completely in six bones. These residual canals demonstrated higher signals
than the cancellous bone in the T1 and T2 images of the MRI. In two out of all 26 bones,
thin nail residuals were found to be surrounded by a 3–4 mm halo effect (Figure 3). The
tri-calcium-phosphate marker at the end of the nail was visible in 24 out of 26 (92%, 95% CI
76% to 98%) forearm bones in the MR images. (Table 3) The formation of intraosseal cysts
was not detected.
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Table 3. Imaging findings of biodegradable nails in MR.
n (26) %
Absorption of the nail
Complete 15 58
Almost complete 11 42
Disappearance of the nail canal
Complete 20 7
Almost complete 6 23
Visible TCP-tip 24 92
Non-visible TCP-tip 2 8
Continuous fatty bone marrow 26 100
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3.3. Other Imaging Findings
In the forearm MRI of the BIN group, no soft tissue or bone oedema were detected,
and fatty bone marrow was intact in all fractured forearm bones. The cortical perforation
of the nail entrance was seen in five out of 26 bones (19%, 95% CI 7% to 39%). The IOM
between the radius and ulna was visible and intact in all cases. Operation-related low-
signal artefacts in the soft tissues were found in 11 out of 15 patients (73%, 95% CI 45% to
92%).
Clinically significant differences were not found in the alignment of the fractured fore-
arm bones when compared with the non-fractured bones, regardless of fixation material.
The lengths of the forearm bones were similar between the fractured and uninjured fore-
arms in both treatment groups. The resorption of the callus was complete in 19 (73%) out of
26 bones in the BIN group and 25 (83%) out of 30 in the ESIN group (95% CI of difference
−33% to 12%). The β-TCP tip of the biodegradable nail was visible in the radiographs of
all bones from the BIN group (Figure 4).
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4. Discussion
The gold-standard method of surgical treatment of children’s forearm shaft fractures
is intramedullary nailing using flexible intramedullary nails [15,21–25,27,28]. However,
there are disadvantages in ESIN; therefore, we developed a new intramedullary fixation
method based on biodegrading implants. In this prospective randomized trial with at least
four years of follow-up, we found that the long-term clinical outcomes of the study method
(BIN) were at least as good as those in the reference method (ESIN). Despite the PLGA
study implants being much less stable than the metal alloy implants used in the reference
method, they were still stable enough to maintain alignment until bone healing. Due to
high elasticity it is assumed to not prevent the remodelling of the fractured forearm bone.
In addition, a secondary operation is not needed for implant removal.
Previously, there have been limitations when using biodegradable material in human
tissue. Therefore, polymers used in bioabsorbable fixation devises in orthopaedic surgery
have been under fast development. Currently, they have special features concerning
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degradation, with the degradation rate being dependent on the used homopolymers. The
study implants used in this research consisted of two polymers that degrade at different
speeds: polyglycolide (PGA) and polylactide (PLA). Böstman et al. [31] reported that PGA
disappeared from the tissue within nine months (36 weeks) when assessed via a light
microscope in an experimental study. Polylevolactic acid (PLLA), which is a stereoisomer
of PLA, has a longer degradation time: Pihlajamäki et al. [32] analysed PLLA implants
in 10 patients with operatively treated displaced malleolar ankle fractures. At the final
follow-up (range of 8 to 52 months postoperatively), all PLLA implants were visible upon
MRI and had maintained their size and shape. Poly-L-lactidehydroxyapatite screws in
anterior cruciate ligament reconstruction were followed via MRI at 2, 5, and 13 years by
Sundarj et al. [33] The bioabsorbable screws had lost their volume at two and five years
(MRI imaging) and were completely resorbed at 13 years. Co-polymer PLGA contains
both rapidly and slowly degrading polymers. The idea of using a co-polymer was to
maintain stability for a sufficiently long time to promote fracture healing while maintaining
a reasonable degrading process. Our study, which had at least four years of follow-up,
strengthened the conception of co-polymer based implants. The bones showed both good
reduction and the fixation material degradation. Previously, non-favourable results of
PLGA screws (L-lactic/co-glycolic acid copolymer) were reported by Balestro et al. [10]
when they treated recurrent anterior shoulder instability using the Latarjet procedure.
Coracoid graft osteolysis was detected in 66.7% (8/12) of the shoulders, and three patients
suffered from recurring instability. The PLGA screws were all resorbed within two years
when imaged via CT. However, CT and MRI are not comparable methods in assessing the
degradation of polymers.
Biodegradable fracture fixation has favourable characteristics in respect to MR imag-
ing, because it does not produce artefacts around the fixation devise.
During the long-term follow-up period, i.e., a mean of 6.8 years after the surgical
treatment with biodegradable intramedullary nailing, the fixation material was completely
absorbed in more than half of the bones (15/26, 57.7%) and almost completely absorbed
in 11 out of 26 (42.3%) bones upon MRI. The remaining small particles of the nails were
thin and faint at the long-term follow-up (Figure 2). This is rather different from previous
short-term findings at the two-year mark, at which the nails were all visible [30]. Even
though the resorption time was longer than previously suspected, the finding supports
the use of the study method. In the present study, there were no complications related to
the degradation process, such as cysts or osteolysis. However, the finding may encourage
further development of the implant material to undergo a more rapid degradation process.
We found that the fatty intramedullary canal had been remodelled at the long-term
follow-up. In six bones, some parts of the nail canals were still visible. These residual
canals demonstrated higher signal than the cancellous bone in the T1 and T2 images of
the MRI. In two out of all 26 bones, thin nail residuals were found to be surrounded by a
3–4 mm halo effect (Figure 3). This is in agreement with the literature, while Pihlajamäki
et al. [34] previously reported a rim of a 1–2 mm halo around the PLLA implants that
was bright in the T2, PD, and fat-saturated images. The clinical importance of the halo
effect is not well understood but it will probably gradually disappear with time upon the
continuation of tissue turnover.
A good clinical long-term recovery was found in all patients treated by either BIN
or ESIN. One isolated patient with biodegradable nails and two patients with titanium
nails reported mild pain in their Mayo elbow performance questionnaires. However, the
mean score for the BIN patients was excellent (99.0, SD 1.87) and similar to that of the
ESIN patients (98.0, SD 3.47). Similarly, the QuickDASH disability scores were excellent
in both groups. The functional recovery, assessed via clinical measurements of range of
movements and strength, were equal for both BIN and ESIN, while the pronation of the
forearm, flexion of the elbow, and volar flexion of the wrist were statistically significantly
better in the BIN group; however, this difference was slight from a clinical point of view.
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The good long-term outcomes of forearm fractures in this research are in line with the
current literature [26,27].
Implant failure occurred in two patients treated with BIN (2/19, 10.5%) vs. none
treated with ESIN (0/16) [28]. These patients with re-fractures were teenaged adolescents,
a 14-year old boy (67 kg) and a 13-year old girl (40 kg). Their clinical and radiographic
results were primarily good. However, they suffered from re-fracture without a new
isolated injury at four weeks and the three-month mark postoperatively, respectively. The
re-fractures were reduced and stabilized by using a plate and screw fixation. Another
two patients, a 10-year old girl and a 9-year old boy suffered from re-fractures related
to new high-energy injuries eight months and ten months post-operatively. Their injury
mechanisms were falling from a scooter and trampoline jumping. The new fractures of
these two patients were treated by using plate and screw fixation.
As a limitation, the removal of the PLGA intramedullary implants would not be
straightforward, if needed in case of a new fracture in the same forearm. In this research,
two patients, aged 9 and 10, suffered from new high-energy fractures in the previously
operated forearms. The removal of the PLGA nails were not attempted; in contrary, open
reduction was performed for both and the holes were drilled through the bone cortices
and the remaining intramedullary implants, when the new fractures were stabilized with a
plate and screws. The need of plate and screw fixation is a disadvantage in that age group,
while a repetitive ESIN by replacing the bent intramedullary nails by the intact ones would
have been possible after traditional ESIN. However, this disadvantage of BIN must be
considered by understanding that ESIN is not complication-free: tendon ruptures, nerve
injuries, delayed union, malunion or non-union and re-fractures have been reported as the
potential adverse events of ESIN [14,22,24,26,28,35,36].
According to the study plan, all operated extremities were immobilized by using
the above-the-elbow cast, regardless on the implants. There is controversial—whether
to implement postoperative immobilization with ESIN or not—but immobilization was
the current practice in our institutions when the study protocol was designed. Due to
lower stability of the BIN implants, we find it clear that postoperative immobilization by
casting is an important part of the treatment: the purpose of the cast is in particular to
hold alignment, while the intramedullary BIN implants prevents the fracture parts from
displacement.
5. Limitations of the Study
Although 30 out of 35 (85.7%) of the enrolled patients participated in the follow-up
portion of the study at least four years following their operation, the overall number of
patients is small. Additionally, during enrolment and operation, the age distribution of the
patients was five to 15 years. The bone characteristics of young children are different from
those of teenagers, which may affect the support power supplied by intramedullary nails,
especially biodegradable nails. A greater sample size would have provided the opportunity
to assess the feasibility of biodegradable nails among different age groups.
6. Conclusions
After a mean follow-up time of 6.8 years, both BIN and ESIN resulted in excellent
clinical outcomes in paediatric forearm shaft fractures. The PLGA biodegradable implants
were completely or close to completely resorbed in all patients according to the MRI, and
no complications related to the biodegrading process were found. However, two implant
failures (2/19, 10.5%) with BIN occurred in teenaged patients shortly after operative
treatment vs. none (0/16) with ESIN. Therefore, we find the BIN technique as an option
particularly in younger children, but further trials are needed to determine the feasibility
of the procedure in older children and teenagers.
Author Contributions: Conceptualization, J.-J.S., W.S.; methodology, J.-J.S., W.S.; software, T.P.;
validation, T.P., M.P., J.-J.S. formal analysis, T.P., M.P., J.-J.S.; investigation, M.P., L.K., A.K., and
J.-J.S.; resources, J.-J.S., W.S., and J.N.; data curation, M.P.; writing—original draft preparation, M.P.;
J. Clin. Med. 2021, 10, 995 11 of 12
writing—review and editing, all authors; visualization, M.P.; supervision, J.-J.S., W.S., and J.N.; project
administration, J.-J.S. All authors have read and agreed to the published version of the manuscript.
Funding: This research did not receive any specific grant from funding agencies in the public,
commercial, or not-for profit sectors.
Institutional Review Board Statement: The study was conducted according to the guidelines of the
Declaration of Helsinki, and originally approved by the Medical Ethics Committee and the Hospital
Ethics Committee of Pirkanmaa Hospital District, Tampere, Finland (§R09231/2011) and recorded in
the annals of the Northern Finland Hospital District, Oulu, Finland. The Medical Ethics Committee
of Northern Finland Hospital District, Oulu, Finland approved the extension of the study (30 January
2019, 112/2018). Permission for the study was also approved by Päijät-Häme Central Hospital for
the patients treated and re-examined at that hospital (6 November 2019, D/2219/13.00.00.00/2019).
Informed Consent Statement: Written informed consent was obtained from eligible paediatric
patients and/or their guardians or the adult patients themselves.
Data Availability Statement: The data presented in this study are available on request from the
corresponding author. The data are not publicly available due to privacy reasons.
Acknowledgments: Juhani Merikanto is highly acknowledged for the conceptualization, methodol-
ogy and project administration of the original study protocol.
Conflicts of Interest: J.-J.S. declares research grants from Alma and KA Snellman Foundation,
Emil Aaltonen Foundation, Foundation of Pediatric Research, and national VTR-funding, J.-J.S. has
consulted with Bioretec Ltd for surgical issues. J.-J.S. is an expert at Patient Insurance Centre. J.-J.S. is
the section Editor of Scandinavian Journal of Surgery and member of the editorial board of Journal of
Children Orthopaedics. The others declare no conflicts of interest.
References
1. Rokkanen, P.; Böstman, O.; Vainionpää, S.; Vihtonen, K.; Törmälä, P.; Laiho, J.; Kilpikari, J.; Tamminmäki, M. Biodegradable
implants in fracture fixation: Early results of treatment of fractures of the ankle. Lancet 1985, 325, 1422–1424. [CrossRef]
2. Ashammakhi, N.; Rokkanen, P. Absorbable polyglycolide devices in trauma and bone surgery. Biomaterials 1997, 18, 3–9.
[CrossRef]
3. Rokkanen, P.; Böstman, O.; Hirvensalo, E.; Partio, E.K.; Mäkelä, E.A.; Pätiälä, H.; Vihtonen, K. Bioabsorbable implants in
orthopedics. Curr. Orthop. 1999, 13, 223–228. [CrossRef]
4. Rokkanen, P.; Böstman, O.; Hirvensalo, E.; Mäkelä, A.; Partio, E.; Pätiälä, H.; Vainionpää, S.; Vihtonen, K.; Törmälä, P. Bioab-
sorbable fixation in orthopaedic surgery and traumatology. Biomaterials 2000, 21, 2607–2613. [CrossRef]
5. Viljanen, J.; Pihlajamäki, H.; Kinnunen, J.; Bondestam, S.; Rokkanen, P. Comparison of absorbable poly-l-lactide and metallic
intramedullary rods in the fixation of femoral shaft osteotomies: An experimental study in rabbits. J. Orthop. Sci. 2001, 6, 160–166.
[CrossRef]
6. Kyrö, A.; Lautiainen, I.; Mäkelä, A.; Södergård, J.; Törmälä, P.; Rokkanen, P. Bioabsorbable intramedullary nail fixation of
clavicular fractures. In Proceedings of the 6th Congress of the European Federation of National Associations of Orthopaedics and
Traumatology, Helsinki, Finland, 4–10 June 2003; p. 246.
7. Waris, E.; Konttinen, Y.T.; Ashammakhi, N.; Suuronen, R.; Santavirta, S. Bioabsorbable fixation devices in trauma and bone
surgery: Current clinical standing. Expert Rev. Med. Devices 2004, 1, 229–240. [CrossRef]
8. Hughes, T.B. Bioabsorbable Implants in the Treatment of Hand Fractures: An Update. Clin. Orthop. Relat. Res. 2006, 445, 169–174.
[CrossRef]
9. Daghino, W.; Bistolfi, A.; Aprato, A.; Massè, A. Bioabsorbable implants in foot trauma surgery. Injury 2019, 50, S47–S55. [CrossRef]
10. Balestro, J.-C.; Young, A.; Maccioni, C.; Walch, G. Graft osteolysis and recurrent instability after the Latarjet procedure performed
with bioabsorbable screw fixation. J. Shoulder Elb. Surg. 2015, 24, 711–718. [CrossRef] [PubMed]
11. Micic, I.; Kholinne, E.; Kwak, J.-M.; Koh, K.-H.; Jeon, I.-H. Osteolysis is observed around both bioabsorbable and nonabsorbable
anchors on serial magnetic resonance images of patients undergoing arthroscopic rotator cuff repair. Acta Orthop. Traumatol. Turc.
2019, 53, 414–419. [CrossRef]
12. Lyons, R.A.; Delahunty, A.M.; Kraus, D.; Heaven, M.; McCabe, M.; Allen, H.; Nash, P. Children’s fractures: A population based
study. Inj. Prev. 1999, 5, 129–132. [CrossRef] [PubMed]
13. Wilkins, K.E. Principles of fracture remodeling in children. Injury 2005, 36, S3–S11. [CrossRef] [PubMed]
14. Flynn, J.; Jones, K.; Garner, M.; Goebel, J. Eleven years’ experience in the operative management of paediatric forearm frac-tures.
J. Pediatr. Orthop. 2010, 30, 313–319. [CrossRef]
15. Schmittenbecher, P. State-of-the-art treatment of forearm shaft fractures. Injury 2005, 36, S-A25–S-A34. [CrossRef] [PubMed]
16. Price, C.T. Acceptable Alignment of Forearm Fractures in Children: Open Reduction Indications. J. Pediatr. Orthop. 2010, 30,
S82–S84. [CrossRef]
J. Clin. Med. 2021, 10, 995 12 of 12
17. Maccagnano, G.; Notarnicola, A.; Pesce, V.; Tafuri, S.; Mudoni, S.; Nappi, V.; Moretti, B. Failure Predictor Factors of Conservative
Treatment in Pediatric Forearm Fractures. BioMed Res. Int. 2018, 2018, 5930106. [CrossRef]
18. Sinikumpu, J.-J.; Lautamo, A.; Pokka, T.; Serlo, W. Complications and radiographis outcome of childrens’s both-bone diaphyseal
forearm fractures after invasive and non -invasive treatment. Injury 2013, 44, 431–436. [CrossRef]
19. Helenius, I.; Lamberg, T.; Kääriäinen, S.; Impinen, A.; Pakarinen, M. Operative treatment of fractures in children is increasing: A
population-based study from Finland. JBJS 2009, 91, 2612–2616. [CrossRef]
20. Kapoor, V.; Theruvil, B.; Edwards, S.; Taylor, G.; Clarke, N.; Uglow, M. Flexible intramedullary nailing of displaced diaphyseal
forearm fractures in children. Injury 2005, 36, 1221–1225. [CrossRef]
21. Garg, N.K.; Ballal, M.S.; Malek, I.A.; Webster, R.A.; Bruce, C.E. Use of Elastic Stable Intramedullary Nailing for Treating Unstable
Forearm Fractures in Children. J. Trauma Inj. Infect. Crit. Care 2008, 65, 109–115. [CrossRef]
22. Fernandez, F.; Eberhardt, O.; Langendörfer, M.; Wirth, T. Non-union of forearm shaft fractures in children after intramedullary
nailing. J. Pediatr. Orthop. B 2009, 18, 289–295. [CrossRef] [PubMed]
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